WO/2002/002076 is referenced by 3 patents.

Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous in an amount sufficient to reach a concentration equivalent to at least about 0.05 $g(m)g/ml dexamethasone within about 48 hours and maintains a concentration equivalent to at least about 0.03 $g(m)g/ml dexamethasone for at least about three weeks.

Title
Methods for treating inflammation-mediated conditions of the eye
Application Number
PCT/US2001/021173
Publication Number
2002/002076
Application Date
July 3, 2001
Publication Date
January 10, 2002
Inventor
Hu Mae W L
Wong Vernon G
Agent
sSHORTLE Rebecca
Assignee
Hu Mae W L
Wong Vernon G
Oculex Pharmaceuticals
IPC
A61K 09/00
A61K 31/57
A61K 31/56
View Original Source